Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Loestrin

Ethinyl Estradiol Norethindrone Acetate

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Loestrin:

 BioPortfolio Logo
Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation 12th January, 2009 Watson Pharmaceuticals, Inc.
HAMILTON, Bermuda and CORONA, Calif., Jan. 12 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) and Warner Chilcott Limited (Nasdaq: WCRX) announced today that they have entered

Companies working in the area of Loestrin from Bioportfolio's Biocorporate database :

 BioPortfolio Logo
Company Name

Warner Chilcott

Warner Chilcott is a leading specialty pharmaceutical company focused on developing, manufacturing and marketing and selling branded prescription pharmaceutical products in women’s healthcare and...
www.warnerchilcott.com/        View full profile
Thumbshot

This page has been viewed 20 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Loestrin across BioPortfolio, or for Loestrin Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.